Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
PP&E Net
Iterum Therapeutics PLC
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
PP&E Net
$508k
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
Perrigo Company PLC
NYSE:PRGO
|
PP&E Net
$1.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
PP&E Net
$235m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
23%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
PP&E Net
$2.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-16%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
PP&E Net
$1.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
PP&E Net
€30.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
See Also
What is Iterum Therapeutics PLC's PP&E Net?
PP&E Net
508k
USD
Based on the financial report for Mar 31, 2024, Iterum Therapeutics PLC's PP&E Net amounts to 508k USD.
What is Iterum Therapeutics PLC's PP&E Net growth rate?
PP&E Net CAGR 5Y
-43%
Over the last year, the PP&E Net growth was -70%. The average annual PP&E Net growth rates for Iterum Therapeutics PLC have been -55% over the past three years , -43% over the past five years .